StonvexLoading…
StonvexStonvexStonvexCore line items from NHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $80.06M | $54.42M | $48.81M | $35.80M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $142.18M | $137.99M | $135.65M | $66.40M |
EPS (Diluted) | $3.02 | $3.13 | $3.13 | $1.48 |
Total Assets | $2.80B | $2.61B | $2.49B | $2.51B |
Total Liabilities | $1.26B | $1.23B | $1.21B | $1.22B |
Cash & Equivalents | $19.62M | $24.29M | $22.35M | $19.29M |
Free Cash Flow OCF − CapEx | $-57.47M | $49.84M | $134.89M | $174.35M |
Shares Outstanding | 48.30M | 45.69M | 43.41M | 43.39M |